Addressing multi-sensory overload, digital burnout, and metabolic disruptions, Clinic Secret emerges as a non-invasive weight management solution grounded in real science and modern lifestyles
Foundayo (Orforglipron) Emerging Oral GLP-1 FDA-approved for: Weight loss in adults (as of February 2026) Dosing: Once daily by mouth, with or without food Device: Oral tablet Foundayo represents a new chemical class
As you lose weight on semaglutide, your levothyroxine dose may need adjustment downward to prevent over-replacement, which can cause tachycardia, anxiety, and other hyperthyroid symptoms
Metformin has been found to increase the abundance of Lactobacillus in rodents with HFD (Zhou et al., 2016
This finding has significant implications: it suggests that the cancer-protective effects of GLP-1 therapy extend substantially beyond weight reduction alone, implicating independent biological mechanisms
Clinically relevant and translational model Standardized and fully characterized experimental conditions Comprehensive virological, clinical and histopathological readouts Ideal for antiviral efficacy studies and candidate ranking If you are developing novel antiviral therapies, our experts are ready to discuss how this model can strengthen your preclinical program and accelerate your path toward clinical development